吸入氧化对ARDS患者通过电阻断断层扫描评估的通风/输液不匹配的影响:一项前性观察性研究
Hongling Zhang1, Xuehui Gao1, Yongran Wu1
1Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Critical care (London, England)
|July 27, 2025
概括
在急性呼吸窘迫综合征 (ARDS) 患者中,吸入氧化 (iNO) 的反应有所不同. 电阻断层扫描 (EIT) 显示,响应者改善了肺 perfusion 分布,而非响应者则经历了不匹配的恶化.
科学领域:
- 生理学 生理学 生理学
- 肺部病理学 肺部病理学
- 医疗成像医学成像
背景情况:
- 急性呼吸困难综合征 (ARDS) 呈现出明显的通风/输液 (V/Q) 不匹配.
- 治疗反应的个体变异性是ARDS管理中的一个挑战.
- 吸入的氧化 (iNO) 用于改善ARDS中的氧化,但其对V/Q不匹配的影响尚未完全理解.
研究的目的:
- 评估吸入氧化 (iNO) 对ARDS患者的通风/输液 (V/Q) 不匹配的影响.
- 用电阻断层扫描 (EIT) 来评估iNO反应中的个体变异性.
- 为了在iNO治疗期间将生理变化与临床参数相关联.
主要方法:
- 机械呼吸ARDS患者的前性生理研究.
- 基于PaO2/FiO2改善的非响应者中iNO (5-40 ppm) 的剂量升级.
- 使用EIT连续监测V/Q分布,以及呼吸和血液动力学参数,持续3小时.
主要成果:
- 36.7%的患者对初始iNO剂量有反应,这与年龄较小和高血压患病率较低有关.
- 响应者在30分钟和3小时后显示腹 perfusion 增加和背部V / Q不匹配减少.
- 非响应者表现出增加的V/Q不匹配与长期高剂量iNO.
结论:
- 在ARDS中对iNO的个体反应是可变的.
- EIT证明iNO可以在响应者中向腹部区域重新分配肺 perfusion.
- iNO可能会改善ARDS中的V/Q匹配,但非响应者需要进一步调查.
关键词:
急性呼吸困扰综合征是什么电阻断层扫描仪电阻断层扫描仪吸入的氧化氧化物肺部 perfusion perfusion 肺部 perfusion 是一种肺部 perfusion 的方法,它是通过肺部 perfusion 进行的.短线运行方式 短线运行更多相关视频
12:29Magnetic Resonance Imaging Quantification of Pulmonary Perfusion using Calibrated Arterial Spin Labeling
Published on: May 30, 2011
13.8K
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.5K
相关概念视频
01:17Assessment of Diffusion and Perfusion
1.1K
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.1K
01:21Acute Respiratory Failure-II
368
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
368